Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor

C. Papi; G. Granata; M. Galluzzo; Raffaele Iorio

doi:10.1007/s10072-022-06498-7

Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor

C. Papi
, G. Granata
, M. Galluzzo
, Raffaele Iorio^*

^*Autore corrispondente per questo lavoro

University of Rome Tor Vergata

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

na

Lingua originale	Inglese
pagine (da-a)	1105-1107
Numero di pagine	3
Rivista	Neurological Sciences
Volume	44
Numero di pubblicazione	3
DOI	https://doi.org/10.1007/s10072-022-06498-7
Stato di pubblicazione	Pubblicato - 2023

All Science Journal Classification (ASJC) codes

Dermatologia
Neurologia (clinica)
Psichiatria e Salute Mentale

Keywords

Antibodies
Autoantibodies
Humans
Interleukin Inhibitors
Interleukin-17
Letter
Muscles
Myasthenia Gravis
adult
antibody
antibody blood level
antibody detection
antibody titer
autoantibody
case report
clinical article
cyclosporine
drug dose reduction
drug tolerability
drug withdrawal
gastrointestinal symptom
human
interleukin 17
male
muscle
muscle specific kinase
myasthenia gravis
neurologic examination
phosphotransferase
prednisone
psoriasis vulgaris
pyridostigmine
secukinumab
single fiber electromyography
steroid therapy
treatment interruption
unclassified drug

Accesso al documento

10.1007/s10072-022-06498-7

Altri file e collegamenti

Cita questo

@article{0a9c64b802b24fe6b8dbb99db7b506b6,

title = "Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor",

abstract = "na",

keywords = "Antibodies, Autoantibodies, Humans, Interleukin Inhibitors, Interleukin-17, Letter, Muscles, Myasthenia Gravis, adult, antibody, antibody blood level, antibody detection, antibody titer, autoantibody, case report, clinical article, cyclosporine, drug dose reduction, drug tolerability, drug withdrawal, gastrointestinal symptom, human, interleukin 17, male, muscle, muscle specific kinase, myasthenia gravis, neurologic examination, phosphotransferase, prednisone, psoriasis vulgaris, pyridostigmine, secukinumab, single fiber electromyography, steroid therapy, treatment interruption, unclassified drug, Antibodies, Autoantibodies, Humans, Interleukin Inhibitors, Interleukin-17, Letter, Muscles, Myasthenia Gravis, adult, antibody, antibody blood level, antibody detection, antibody titer, autoantibody, case report, clinical article, cyclosporine, drug dose reduction, drug tolerability, drug withdrawal, gastrointestinal symptom, human, interleukin 17, male, muscle, muscle specific kinase, myasthenia gravis, neurologic examination, phosphotransferase, prednisone, psoriasis vulgaris, pyridostigmine, secukinumab, single fiber electromyography, steroid therapy, treatment interruption, unclassified drug",

author = "C. Papi and G. Granata and M. Galluzzo and Raffaele Iorio",

year = "2023",

doi = "10.1007/s10072-022-06498-7",

language = "English",

volume = "44",

pages = "1105--1107",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia s.r.l.",

number = "3",

}

TY - JOUR

T1 - Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor

AU - Papi, C.

AU - Granata, G.

AU - Galluzzo, M.

AU - Iorio, Raffaele

PY - 2023

Y1 - 2023

N2 - na

AB - na

KW - Antibodies

KW - Autoantibodies

KW - Humans

KW - Interleukin Inhibitors

KW - Interleukin-17

KW - Letter

KW - Muscles

KW - Myasthenia Gravis

KW - adult

KW - antibody

KW - antibody blood level

KW - antibody detection

KW - antibody titer

KW - autoantibody

KW - case report

KW - clinical article

KW - cyclosporine

KW - drug dose reduction

KW - drug tolerability

KW - drug withdrawal

KW - gastrointestinal symptom

KW - human

KW - interleukin 17

KW - male

KW - muscle

KW - muscle specific kinase

KW - myasthenia gravis

KW - neurologic examination

KW - phosphotransferase

KW - prednisone

KW - psoriasis vulgaris

KW - pyridostigmine

KW - secukinumab

KW - single fiber electromyography

KW - steroid therapy

KW - treatment interruption

KW - unclassified drug

KW - Antibodies

KW - Autoantibodies

KW - Humans

KW - Interleukin Inhibitors

KW - Interleukin-17

KW - Letter

KW - Muscles

KW - Myasthenia Gravis

KW - adult

KW - antibody

KW - antibody blood level

KW - antibody detection

KW - antibody titer

KW - autoantibody

KW - case report

KW - clinical article

KW - cyclosporine

KW - drug dose reduction

KW - drug tolerability

KW - drug withdrawal

KW - gastrointestinal symptom

KW - human

KW - interleukin 17

KW - male

KW - muscle

KW - muscle specific kinase

KW - myasthenia gravis

KW - neurologic examination

KW - phosphotransferase

KW - prednisone

KW - psoriasis vulgaris

KW - pyridostigmine

KW - secukinumab

KW - single fiber electromyography

KW - steroid therapy

KW - treatment interruption

KW - unclassified drug

UR - https://publicatt.unicatt.it/handle/10807/227848

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85141682465&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85141682465&origin=inward

U2 - 10.1007/s10072-022-06498-7

DO - 10.1007/s10072-022-06498-7

M3 - Article

SN - 1590-1874

VL - 44

SP - 1105

EP - 1107

JO - Neurological Sciences

JF - Neurological Sciences

IS - 3

ER -

Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo